In the mouse models for Saethre-Chotzen syndrome (single or compound Msx2-Twist mutants), osteoblastic differentiation markers were reduced by E12.5, while proliferation is not reduced until E14.5 [22]. The gene discussed is MSX2; the disease is Saethre-Chotzen syndrome.